Short-term treatment using insulin-like growth factor-1 (IGF-1) improves life expectancy of the delta-sarcoglycan deficient hamster.

Serose, Armelle; Salmon, André; Fiszman, Marc Y; Fromes, Yves

Serose, Armelle; Salmon, André; Fiszman, Marc Y; Fromes, Yves.

Affiliation

Serose A; Institut de Myologie, Institut National de la Santé et de la Recherche Médicale, U582, Université Pierre et Marie Curie, AP HP, CHU Pitié-Salpêtrière, IFR 14, Paris, France.

J Gene Med ; 8(8): 1048-55, 2006 Aug.

Article in En | MEDLINE | ID: mdl-16779861

Subject(s)

Insulin-Like Growth Factor I/therapeutic use; Longevity/drug effects; Sarcoglycans/deficiency; Animals; Body Weight/drug effects; Cardiomyopathy, Dilated/drug therapy; Cricetinae; Echocardiography; Electrocardiography; Gene Deletion; Humans; Insulin-Like Growth Factor I/genetics; Insulin-Like Growth Factor I/metabolism; Insulin-Like Growth Factor I/pharmacology; Life Expectancy; Male; Mesocricetus/genetics; Organ Size/drug effects; Recombinant Proteins/pharmacology; Recombinant Proteins/therapeutic use; Sarcoglycans/genetics; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor I / Sarcoglycans / Longevity Type of study: Prognostic_studies Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2006 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links